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Summary
Objective: We have demonstrated in bovine chondrocytes that nitric oxide (NO) mediates IL1 dependent apoptosis under conditions of
oxidant stress. This process is accompanied by activation of c-Jun NH2-terminal kinase (JNK; also called stress-activated protein kinase).
In these studies we examined activation of JNK in explant cultures of human osteoarthritic cartilage obtained at joint replacement surgery
and we characterized the role of peroxynitrite to act as an upstream trigger.
Design: A novel technique to isolate chondrocyte proteins (<10% of total cartilage protein) from cartilage specimens was developed. It was
used to analyse JNK activation by a western blot technique. To examine the hypothesis that chondrocyte JNK activation is a result of
increased peroxynitrite, in vitro experiments were performed in which cultured chondrocytes were incubated with this oxidant.
Results: Activated JNK was detected in the cytoplasm of osteoarthritis (OA) affected chondrocytes but not in that of controls. In vitro,
chondrocytes produce NO and superoxide anion. IL-1 (48 h), which induces nitric oxide synthase, resulted in an activation of JNK; this effect
was reversed by N-monomethylarginine (NMA). TNF treated chondrocytes at 48 h produce superoxide anion (EPR method). Exposure of
cells to peroxynitrite led to an accumulation of intracellular oxidants, in association with JNK activation and cell death by apoptosis.
Conclusion: We suggest that JNK activation is among the IL-1 elicited responses that injure articular chondrocytes and this activation of JNK
is dependent on intracellular oxidant formation (including NO peroxynitrite). In addition, the extraction technique here described is a novel
method that permits the quantitation and study of proteins such as JNK involved in the signaling pathways of chondrocytes within
osteoarthritic cartilage. © 2001 OsteoArthritis Research Society International
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Chondrocytes are capable of adaptation and remodeling in
response to mechanical force that, in healthy tissue, stimu-
lates anabolic pathways1. However, this response is highly
sensitive to local environmental changes, often modified
by altered biomechanical forces, which can result in the
release of autocrine catabolic cytokines leading to a loss of
proteoglycan2. We and others have implicated inducible
nitric oxide synthase (iNOS) as an inflammatory mediator
of osteoarthritis (OA)3–5. NO can react with other free
radicals to generate molecules such as peroxynitrite lead-
ing to the accumulation of injurious intracellular oxidants
and DNA damage6–8. It is possible that NO and peroxy-
nitrite account for the local environmental changes which
interfere with chondrocyte anabolic pathways.
We have previously reported that the MAPK extracellular
signal regulated kinase 1 and 2 (ERK) acts to promote294constitutive and growth factor elicited (e.g. IGF-1, FGF)
proteoglycan synthesis and that iNOS expression is associ-
ated with the inhibition of (ERK)9. Two other MAPK path-
ways, p38 and the stress-activated protein kinases
[SAPKs, also known as C-Jun terminal kinase (JNK)],
appear to serve roles in cellular responses to stress and/or
apoptosis. p38 is uniquely sensitive to activation by osmotic
stress or bacterial endotoxin (LPS)10. Although the role of
NO was not evaluated, activation of JNK led to over-
expression of metalloproteinases and in some cases it
promoted apoptosis11,12. Taken together, the regulation
and balanced activation of MAPK signaling pathways in
chondrocytes regulates physiological and pathophysiologi-
cal cell responses.
A systematic examination of the relationship between
MAPK pathway activation, iNOS expression and chondro-
cyte injury in OA has not been undertaken. However,
because of a central role of MAPK in cell function it is
tempting to speculate that chondrocyte injury in OA reflects
a dysregulation of physiologic MAPK activation pathways.
Accordingly, the present study was initiated to examine two
MAPK pathways, ERK and JNK, in chondrocytes of
patients with OA. To define a molecular basis for the MAPK
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CARTILAGE ORGAN CULTURE
Articular cartilage was collected from patients under-
going total knee joint replacement. Total tissue was pooled
without discrimination to normal or focal disease areas. The
diagnosis of OA was confirmed by pathology examination.
Each patient sample was analysed separately, the patient
population included three male and nine female patients,
and we found no relation between measurements (JNK
activation) and the sex or age of the patients or the use
of particular medications. Normal human cartilage was
obtained from autopsy specimens (NDRI, Philadelphia).
Tissue protocols included (1) fixation in 4% paraformalde-
hyde, (2) immediate freezing of tissue at −80°C or prep-
aration as uniform cartilage slices measuring 10×10 mm
which were placed in Falcon six-well flat-bottomed tissue
culture plates. The cartilage organ cultures were main-
tained in complete Ham’s F-12 plus P/S, as previously
described13. Cartilage explants were incubated in the
absence and presence of NMA (1 mM) and IL-1 (5 ng/ml)
After 48 h, fluid was analysed for NO release by measuring
NO2- by Griess assay and tissue was immediately frozen
at −80°C.CARTILAGE EXTRACTION TECHNIQUES
Slices from articular cartilage affected by OA were frozen
at −80°C, milled to a fine particulate in liquid nitrogen using
a mortar and pedestal and separated into two fractions.
Extract was obtained as described by Amin et al.13. Briefly,
the guanidine SDS treatment involved a treatment of carti-
lage with extraction buffer A (10 mM Tris pH 7.5, 150 mM
NaCl, 1 mM EDTA); then a sequential treatment with
10 mM Tris pH 7.5, 150 mM NaCl, 1 mM EDTA plus 4 M
guanidine HCl and 10% SDS (extraction buffer B).
Alternatively, we developed an adsorption chromatog-
raphy method, which we describe for the first time in this
text. Milled cartilage (0.5 g) is homogenized for 30 s at 4°C
in 1.4 ml extraction buffer C (10 mM Tris, 1 mM EDTA,
5 mM vanadate, 1 mM EGTA, 25 mM NaF, 5 g/ml
aprotinin, 1 mM PMSF). An additional 0.6 ml of extraction
buffer C was added, followed by a second homogenization
(30 s, 4°C). The addition of 1 ml of 20 mM Tris, 0.1 M NaCl,
0.4 M LiBr, 0.1% NP40 and 1 mM EDTA leads to a new
mixture (extraction buffer D). A slurry (0.2 ml) of controlled
pore glass beads (Sigma, dissolved 1:1 in 50 mM acetate
pH 5.5) per ml of sample in extraction buffer D and 3 ml of
50 mM acetate pH 5.5, 1 mM EGTA, 2 mM Na vanadate,
25 mM NaF, 0.1 M LiBr. This mixture is incubated at 4°C on
a rotating platform. After 3 h, the beads were harvested,
washed in 10 mM Tris, 1 mM EDTA (4°C). The sample
was either placed in SDS sample buffer and boiled or
analysed for catalase activity (see below). Aliquots of
beads containing 500 units of catalase were stored
at −80°C.WESTERN BLOT ANALYSIS
Proteins were resolved on 10% SDS-PAGE gels and
transferred to nitrocellulose. Blots were incubated withanti-actin (Sigma), anti-phosphoERK (New England
Biolabs), anti-total JNK, or activated JNK (both New
England Biolabs) and rabbit anti-Nitrotyrosine (UBI). Blots
were incubated with goat anti-rabbit antibody with peroxi-
dase and then with detection by chemiluminescence. Pro-
tein bands were quantitated by densitometric gel scans
(UMAX scanner, model UC630).HISTOLOGY
Cartilage sections were fixed in paraformaldehyde and
cryostat sections were prepared for staining. The staining
protocol involved reaction with a rabbit polyclonal antibody
to activated JNK (New England Biolabs). Sections were
then incubated with a secondary antibody which was con-
jugated to alkaline phosphatase and then with a detection
dye. The preparations were counterstained with eosin
and phase contrast was used to detect cells positive for
anti-JNK staining, which were recorded by photography.ANALYSIS OF CARTILAGE EXTRACTS FOR CATALASE AND
HYALURONIC ACID CONTENT
Catalase (samples in extraction buffer A–D) was
measured by quantitating oxygen generated from the
decomposition of H2O2 by catalase using a Clark electrode.
Hyaluronic acid was analysed using a RIA by following the
instructions of the manufacturer (Biomedical Technologies
Inc.).EPR MEASUREMENTS
Spin trapping measurements of oxygen radicals were
performed on 107 cells per ml in phosphate-buffered saline
(PBS) with 50 mM 5,5-dimethyl-1-pyrroline N-oxide
(DMPO; Sigma). EPR spectra were recorded in a flat cell at
room temperature with a Bruker ER 300 spectrometer as
previously described14.DATA VARIABILITY
Data were analysed as the mean and the standard error
of the mean. The levels of significance were calculated
using the Student’s t-test.Results
Activated JNK is detected in OA cartilage but not in
normal cartilage. MAPK activation was examined in 12 OA
patients and two normal controls as described below.
Cartilage sections were prepared from osteoarthritic
human knee obtained at the time of joint replacement
(Fig. 1). MAPK activation was measured by probing the
tissue section of patient CD with either an antibody to either
the activated form of JNK or an antibody that recognizes
total (both inactive and active) JNK. As shown in panel C,
activation of stress-activated protein kinase was detected
in the majority of cells in osteoarthritic cartilage. All cells in
the cartilage section reacted positive with an antibody that
recognized total JNK; the cells failed to react with an
isotype control antibody (panel A). Although it has been
previously reported that exposure of chondrocytes to cata-
bolic cytokines such as IL-1 results in an acute activation ofactivities, cultures of bovine chondrocytes were established
to examine the role of nitric oxide and resultant peroxy-
nitrite to alter chondrocyte MAPK activation.
296 R. Clancy et al.: Activation of stress-activated protein kinaseFig. 1. Activation of stress activated protein kinase in osteoarthritic cartilage. Cartilage sections were isolated from osteoarthritic human knee
obtained at the time of joint replacement (age 80, female). Cartilage chips from OA affected cartilage were fixed in paraformaldehyde and
cryostat sections were prepared for staining with primary antibody (anti-activated JNK, anti-total JNK or isotype control antibody) and
detection by a secondary antibody which was conjugated to alkaline phosphatase. After employing a detection dye the preparation were
counterstained with eosin prior to recording by photography. Stains of OA cartilage specimen correspond to polyclonal rabbit IgG control (A),
total (active and inactive) JNK (B) and activated form of JNK (C).Fig. 2. Characterization of OA cartilage extract (from two separate
donors) after use of the adsorption extraction technique to isolate
chondrocyte protein. Extract of chondrocyte proteins was analysed
by Western blot for catalase, rho A andTII collagen. Human OA
cartilage chips from two separate donors were homogenized
(lysate) and purified by adsorption chromatography (beads). After
separation by SDS gels, the gel was stained by coomaasie (upper
panel). A duplicate set was transferred to nitrocellulose and probed
for catalase (upper western blot), the ras related G protein, rho A
(middle panel) or Type II collagen (lower panel). Note that the
protein extract (beads) are enriched in chondrocyte proteins (cata-
lase, rho A) but not matrix (type II collagen).JNK11, this is the first report of activation of JNK in diseased
cartilage.
In order to further characterize this finding and compare
osteoarthritic with normal cartilage more quantitatively, we
developed a novel extraction technique employing adsorp-
tion chromatography to isolate chondrocyte proteins. A
common property of many proteins from a wide spectrum of
sources is a capacity to reversibly adsorb to glass sur-
faces15. We adapted this technique to cartilage as we
sought: (1) to retrieve cellular proteins in a functionally
active state and (2) to exclude matrix components (colla-
gen, proteoglycan, hyaluronic acid). Osteoarthritic cartilage
was obtained and divided into two equal fractions. The first
was extracted using a SDS-guanidine extraction and the
second was treated with the adsorption technique. In both
isolates we evaluated the recovery of catalase (chondro-
cyte protein) and hyaluronic acid (matrix component). The
adsorption technique completely eliminated the contamina-
tion of the isolate by hyaluronic acid or type II collagen (Fig.
2). In addition, the isolate was enriched in intracellular
proteins, JNK (described below), rhoA, and catalase. The
latter was recovered in a functionally active form and we
obtained a protein fraction that was enriched three-fold in
the specific activity of chondrocyte catalase. In contrast, the
protein isolate using the SDS-guanidine extraction failed to
increase the specific activity of catalase or to eliminate
hyaluronic acid.
When the adsorption technique was used to extract
cellular proteins from cartilage chondrocytes, we observed
that activated JNK was detected in OA patients, but not in
normal human cartilage (Fig. 3). The blot was sequentially
probed with an antibody to activated JNK and then total
JNK. In addition, the blot was probed for actin as a protein
loading control. Consistent with the immunostaining, the
OA extract contained activated JNK; two isoforms were
detected (JNK-2 and JNK-1, Mr 55 kDa and 46 kDa,
respectively; lane 3). In a different patient activated JNK
was also detected (lane 4). Moreover, activated JNK was
detected using the immunoblot technique in all OA patients
(N=12, not shown). A common feature is that the intensity
of activated JNK Mr 55 kDa (JNK 2) band was three-fold
stronger than the 46 kDa (JNK 1) band. The recovery of
actin and total JNK (phosphorylated+non-phosphorylated
JNK, not shown) was similar between normal and OA
cartilage specimens.
Endogenous NO is linked to the expression of the
activated form of JNK in human osteoarthritic cartilage.
Osteoarthritic cartilage explants were pre-incubated for48 h in the presence or absence of IL-1 (5 ng/ml) and
L-N-monomethylarginine (NMA) (1.0 mM). Spontaneous
NO release was 1.5 M/g wet weight, consistent with the
previous report that human OA-affected cartilage
spontaneously produces NO13. IL-1 increased NO produc-
tion to 8.3 M, which was reduced to 2.9 M in the pres-
ence of L-NMA. Chondrocyte protein was isolated and
Osteoarthritis and Cartilage Vol. 9, No. 4 297analysed for JNK activation in osteoarthritic cartilage speci-
mens. IL-1 increased JNK activation above baseline by 5.3
fold (Fig. 4, assessed by phosphoimager; control=1 phos-
phoimager unit); IL-1 augmentation was reduced by L-NMA
treatment (5.3 vs 2 phosphoimager units).
Exposure of chondrocytes to TNF leads to release of
peroxynitrite and superoxide anion. A focus on ‘upstream’
events that act to trigger JNK activation was next evaluated
in studies that measured the capacity of chondrocytes
to produce peroxynitrite and superoxide anion. In these
studies, we examined TNF, which, like IL-1, is a known
activator of JNK8,11. Cells were pre-incubated in the pres-
ence or absence of TNF (10 ng/ml, 48 h) and cells were
stained with antinitrotyrosine, a ‘footprint’ of peroxynitrite,
or were analysed for superoxide anion release by an EPR
method. The expression of nitrotyrosine was present in
TNF treated chondrocytes but not controls (not shown).
Because nitrated protein forms when cells undergo oxidant
stress, a focus was placed on oxidant release, which was
measured for 5 min in the presence of DMPO by an EPR
method. We observed that TNF treated chondrocytes, but
not control cells, released oxidants as indicated by an EPR
signal with a typical intensity ratio of 1:2:2:1 and hyperfine
coupling of 15G (DMPO-OH, Fig. 5).
Exposure of chondrocytes to peroxynitrite results in
activation of JNK (and not ERK) in association with
apoptosis (Fig. 6). To test the hypothesis that JNK acti-
vation is secondary to peroxynitrite generated by increased
expression of iNOS, JNK activation was measured in theDiscussion
Our results indicate that activated C-Jun terminal kinase
(JNK) was detected in the cytoplasm of OA chondrocytes,
but not in healthy controls. Several findings indicated a role
of NO derived from iNOS to act as a signal to trigger JNK.
(1) Treatment with cytokines, which induce nitric oxide
synthase, results in further activation of JNK; this effect is
reversed by N-monomethylarginine (NMA). (2) Exposure
of chondrocytes to cytokines led to the accumulation of
intracellular oxidants including peroxynitrite and super-
oxide anion. (3) Peroxynitrite treatment resulted in the
activation of JNK but not ERK (Fig. 7). This redirection
of MAPK signaling pathways is associated with an
apoptosis-inducing activity.
Intracellular reactive oxygen species (ROS) have been
recognized to act as signaling intermediates for cytokines,
including IL-1 and TNF and to activate JNK/SAPK16,17. A
possible link among nitric oxide, MAPK and chondrocyte
dysfunction was indicated by the finding that experimental
rodent adjuvant-induced arthritis (AIA) is attenuated by
co-infusion of either oxygen radical scavengers18 or the
NOS inhibitor, L-NMA19. Previous in vitro studies have
been limited to monolayer chondrocyte studies because of
the difficulty involved in isolation and characterization of
chondrocyte proteins in cartilage specimens. In this study,
we report a novel technique to isolate chondrocyte proteins
from osteoarthritic cartilage obtained at surgery from
patients undergoing joint replacement. MAPK signaling
was assessed by Western blot of extracted chondrocyte
proteins using specific antibodies that report activated and
total SAPK/JNK. For example, SAPK/JNK (Thr183/Tyr185)Fig. 3. Detection of activated JNK in OA cartilage but not normal
cartilage. Chondrocyte protein was extracted using controlled pore
glass beads of two OA patients and two healthy controls. The blot
was probed with an antibody to actin or activated JNK. Note that
activated JNK was detected in both patients (lane 3,4). In contrast,
active JNK was absent in healthy control. The intensity of activated
JNK Mr 55 kDa band was three-fold stronger than the 46 kDa
band.Fig. 4. Endogenous NO is linked to the expression of the activated
form of JNK in human OA cartilage. Human OA cartilage chips
were exposed to IL-1 in the absence and presence of NMA (48 h,
37°C). Protein fraction obtained using adsorption chromatography
were separated by SDS gels and transferred to nitrocellulose.
Blots were sequentially probed with anti-activated JNK, anti-total
JNK (active and inactive) (N=3).Fig. 5. Exposure of chondrocytes to TNF led to release of
superoxide anion. Chondrocytes were cultured as passage one
cells with or without TNF (10 ng/ml; 48 h). Cells were then
removed from culture and the release of superoxide anion was
determined by the EPR method described in Methods. Note the
characteristic spectrum for DMPOH, which is present in TNF
treated cells (lower spectrum) and not control (upper spectrum).
(Experiment was performed twice in duplicate.)presence or absence of peroxynitrite. We found that expo-
sure of chondrocytes to peroxynitrite (10 M; 30 min)
resulted in the activation of JNK and not ERK. We
characterized the nuclear morphology of control and
peroxynitrite-challenged cells. Cells adhered to glass
coverslips were pre-incubated as control and peroxynitrite
treated cells (10 M peroxynitrite, 30 min). After treatment
cells were stained with Hoescht 33258. We observed
that peroxynitrite treatment induced apoptosis (nuclear
fragmentation); in addition the nuclei in this group were
markedly condensed. The apoptosis response was in-
creased by co-addition of the polyADP ribose inhibitor,
3 aminobenzimide (58% vs 30%).
298 R. Clancy et al.: Activation of stress-activated protein kinaseantibody detects SAPK/JNK only when dually phosphor-
ylated at Thr183/Tyr18520. As this dual phosphorylation is
essential for kinase activity, phosphorylation at this site is
a marker of SAPK/JNK activation. Using this extraction
technique, we were able to demonstrate activated MAPK
signaling of chondrocytes within osteoarthritic cartilage.
These data suggest a cascade of events that is initiated
by the expression of inducible nitric oxide synthase (iNOS).
The induction of iNOS in OA chondrocytes results in the
inhibition MAPK extracellular signal-regulated kinases 1
and 2 (ERK), which regulate constitutive and growth factor
elicited (e.g. IGF-1, FGF) proteoglycan synthesis9. In con-
trast, increased NO due to iNOS up-regulation in concert
with increased oxidant production results in peroxynitrite
generation which we show activates the JNK pathway.
Since Frisch and Ruoslahti suggested that in normal cells
the apoptosis-inducing activity of JNK is counteracted
by extracellular signal-regulated kinases (ERK)21, it is
possible that the altered JNK/ERK balance secondary to
peroxynitrite underlie the death pathway via apoptosis.
In summary, increased NO and oxidant production in
chondrocytes, as is observed in osteoarthritic cartilage,
results in the potential activation of the JNK over the ERK
MAP kinase pathway. We suggest that this imbalance of
normal MAP kinase pathway activation contributes to
chondrocyte injury in OA.Fig. 7. A model hypothesis explains the role of peroxynitrite
to contribute to the catabolic phenotype of OA chondrocytes.
Exposure of chondrocytes to TNF or IL-1 leads to an inhibition of
ERK and an activation of JNK secondary to peroxynitrite formation.Fig. 6. Exposure of chondrocytes to peroxynitrite results in acti-
vation of JNK and not ERK. Chondrocytes were cultured as
passage one cells with or without peroxynitrite (10 M, 30 min).
Panel A. Cells were lysed. The sequential stains using the Western
blot technique determined the levels of phosphoJNK and phos-
phoERK (Representative data from N=3). Panel B. Cells were
stained with Hoescht 33258 and rhodamine phalloidin. The perox-
ynitrite treated chondrocytes were apoptotic as evidenced by
nuclear fragmentation. In contrast, control exhibit symmetrically
round nuclei. Note in panel B (middle and lower pictures) that
condensed nuclei in the peroxynitrite group and in the
peroxynitrite+PolyADP ribose polymerase inhibitor were 30% and
58% of the total cells respectively (average determined at three
separate fields).Acknowledgments
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